HNB
MNTA

Huntington National Bank’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Huntington National Bank’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-125
Closed -$1K – 1918
2018
Q4 		$1K Hold
125
– – ﹤0.01% 1619
2018
Q3 		$3K Hold
125
– – ﹤0.01% 1586
2018
Q2 		$3K Buy
+125
New +$2.68K ﹤0.01% 1512

Other funds holding MNTA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Huntington National Bank's MNTA Position: Q1 2019 in Review

Huntington National Bank sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q1 2019, closing a stake of 125 shares — an estimated $1K sold.

Huntington National Bank first reported a position in MNTA in Q2 2018 and held it in 3 quarters. The position peaked at $3K in Q3 2018. 147 funds tracked by Wall St. Rank hold MNTA as of Q1 2019.

  • Huntington National Bank reported no remaining Momenta Pharmaceuticals, Inc. position as of Q1 2019 after selling out during the quarter.
  • Huntington National Bank sold 125 Momenta Pharmaceuticals, Inc. shares in Q1 2019, an estimated $1K.
  • Huntington National Bank first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2018 and held it in 3 quarters.
  • Huntington National Bank's Momenta Pharmaceuticals, Inc. position peaked at $3K in Q3 2018.
  • 147 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q1 2019.

Based on Huntington National Bank's 13F filing for Q1 2019, filed 9 Apr 2019.